Finance

Lists
300723:SHE
ApicHope Pharmaceutical Group Co Ltd
CNÂ¥30.86
+0.82%
(+0.25) 1D
Oct 16, 3:04:07 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300723...
Open
CNÂ¥31.08
High
CNÂ¥31.70
Low
CNÂ¥30.39
Mkt. cap
14.20B
Avg. vol.
5.52M
Volume
3.63M
P/E ratio
63.20
52-wk high
CNÂ¥58.99
52-wk low
CNÂ¥29.31
EPS
CNÂ¥0.49
Shares outstanding
453.19M
No. of employees
1K
Open
CNÂ¥31.08
High
CNÂ¥31.70
Low
CNÂ¥30.39
Mkt. cap
14.20B
Avg. vol.
5.52M
Volume
3.63M
P/E ratio
63.20
52-wk high
CNÂ¥58.99
52-wk low
CNÂ¥29.31
EPS
CNÂ¥0.49
Shares outstanding
453.19M
No. of employees
1K
News stories
From web sources and news partners
About ApicHope Pharmaceutical Group Co Ltd
CEO-
Employees1.29K
FoundedFeb 4, 2002
Headquarters-
SectorPharmaceutical industry
Websiteapichope.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
230.21M
118.27M
385.47M
106.25M
Cost of goods sold
88.31M
84.90M
130.76M
78.53M
Cost of revenue
88.31M
84.90M
130.76M
78.53M
Research and development expenses
21.84M
51.68M
38.05M
40.32M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
170.98M
121.51M
207.76M
109.78M
Operating expense
199.25M
171.41M
231.13M
172.47M
Total operating expenses
287.56M
256.31M
361.89M
251.00M
Operating income
-57.36M
-138.04M
23.58M
-144.75M
Other non operating income
43.29M
-44.07M
-1.07M
441.76K
EBT including unusual items
-58.10M
-213.72M
592.69M
-138.68M
EBT excluding unusual items
-20.64M
-209.76M
592.77M
-169.01M
Income tax expense
7.32M
-10.45M
75.58K
-27.91M
Effective tax rate
-12.61%
4.89%
0.01%
20.13%
Other operating expenses
6.48M
2.91M
-14.68M
22.97M
Net income
-62.54M
-201.71M
594.38M
-109.65M
Net profit margin
-27.17%
-170.56%
154.20%
-103.20%
Earnings per share
-
-
-
-
Interest and investment income
7.28M
-
586.15M
-
Interest expense
-13.87M
-27.55M
-15.89M
-10.78M
Net interest expenses
-6.59M
-27.55M
570.26M
-10.78M
Depreciation and amortization charges
-
-
-
-
EBITDA
-12.88M
-90.05M
71.57M
-94.96M
Gain or loss from assets sale
81.68K
1.16M
-
-468.94K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps